Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?

Munoz-Price, 2008, Acinetobacter infection, NEJM, 358, 1271, 10.1056/NEJMra070741 Catalano, 1999, Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases, J Hosp Infect, 42, 27, 10.1053/jhin.1998.0535 Fournier, 2006, The epidemiology and control of Acinetobacter baumannii in health care facilities, Clin Infect Dis, 42, 692, 10.1086/500202 Jawad, 1998, Exceptional desiccation tolerance of Acinetobacter radioresistens, J Hosp Infect, 39, 235, 10.1016/S0195-6701(98)90263-8 Wendt, 1997, Survival of Acinetobacter baumannii on dry surfaces, J Clin Microbiol, 35, 1394, 10.1128/jcm.35.6.1394-1397.1997 Seifert, 1995, Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality, Medicine (Baltimore), 74, 340, 10.1097/00005792-199511000-00004 Eliopoulos, 2008, Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options, Clin Infect Dis, 46, 1254, 10.1086/529198 Marchaim, 2007, Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii, J Clin Microbiol, 45, 1551, 10.1128/JCM.02424-06 Park, 2013, The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies, PLoS ONE, 8, e65026, 10.1371/journal.pone.0065026 Kim, 2014, Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections, Chonnam Med J, 50, 37, 10.4068/cmj.2014.50.2.37 Kwon, 2007, Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia, J Antimicrob Chemother, 59, 525, 10.1093/jac/dkl499 Cai, 2012, Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies, J Antimicrob Chemother, 67, 1607, 10.1093/jac/dks084 Weinstein, 2007, Look before you leap: active surveillance for multidrug-resistant organisms, Clin Infect Dis, 44, 1101, 10.1086/512820 Apisarnthanarak, 2008, A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study, Clin Infect Dis, 47, 760, 10.1086/591134 Latibeaudiere, 2015, Surveillance cultures growing carbapenem-resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study, Clin Infect Dis, 60, 415, 10.1093/cid/ciu847 Garner, 1988, CDC definitions for nosocomial infections, 1988, Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3 Sarikonda, 2010, Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment, Crit Care Med, 38, 1991, 10.1097/CCM.0b013e3181eeda3f CaLS, 2011 Jang, 2014, Active surveillance of the trachea or throat for MRSA is more sensitive than nasal surveillance and a better predictor of MRSA infections among patients in intensive care, PLoS ONE, 9, e99192, 10.1371/journal.pone.0099192 Tsiatsiou, 2015, Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit, Eur J Pediatr, 174, 65, 10.1007/s00431-014-2365-8 Hong, 2012, Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii infection in a pediatric intensive care unit, Pediatr Infect Dis J, 31, 685, 10.1097/INF.0b013e318256f3e6 Valencia, 2009, Nosocomial outbreak of infection with pan–drug-resistant Acinetobacter baumannii in a tertiary care university hospital, Infect Control Hosp Epidemiol, 30, 257, 10.1086/595977 Choi, 2010, Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program, J Korean Med Sci, 25, 999, 10.3346/jkms.2010.25.7.999 Maragakis, 2008, Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures, JAMA, 299, 2513, 10.1001/jama.299.21.2513